CTOs on the Move

Metabolon

www.metabolon.com

 
Metabolon, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Durham, NC. To find more information about Metabolon, Inc., please visit www.metabolon.com
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.metabolon.com
  • 617 Davis Drive Suite 100
    Morrisville, NC USA 27560
  • Phone: 919.572.1711

Executives

Name Title Contact Details

Funding

Metabolon raised $21.7M on 08/28/2020

Similar Companies

Vireo Systems

At Vireo Systems we develop, manufacture and market products and brands that enhance the health of humans and animals. Our company is dedicated to maintaining excellence in all production processes and protecting the environment while delivering safe, ...

Rexton

Rexton is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pharos Life

Pharos Life is a Cambridge, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TimelyMD

TimelyCare is a virtual health and well-being platform that provides college and university students with access to 24/7 mental, emotional, and physical care from anywhere.

Schulman Associates Institutional Review Board

Since 1983, Schulman has provided the research community with IRB review services of the highest quality. In establishing the IRB, our founders sought to promote clinical research by helping to safeguard the rights and welfare of clinical research subjects. Schulman’s team of dedicated professionals seeks to provide timely, quality services based on the foundation of respect for persons, beneficence and justice. Through continuous quality improvement and rigorous training on human subject protection, Schulman provides thorough, ethical, responsive and thoughtful review of research studies. By combining impeccable review standards, savvy industry insight, responsive customer service and innovative technological solutions, Schulman creates a review experience that goes beyond the expected. We look forward to continued collaboration with our colleagues in North America and around the world as we uphold our mission to protect the rights and welfare of clinical research subjects.